Skip to main content

Table 4 Association of analyzed SNPs with colon cancer risk

From: Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population

Genotype

Cases, n = 150 (%)

Controls, n = 150 (%)

ORa (95%CI)

p-value

MMP-1(rs1799750)

 1G/1G

38 (25.3)

49 (32.7)

1

 1G/2G

75 (50)

66 (44)

1.49 (0.87–2.55)

0.15

 2G/2G

37 (24.7)

35 (23.3)

1.34 (0.70–2.56)

0.37

MMP-2(rs243865)

 CC

88 (58.7)

88 (58.7)

1

 CT

53 (35.3)

54 (36)

1.01 (0.59–1.67)

0.99

 TT

9 (6)

8 (5.3)

1.27 (0.46–3.52)

0.65

MMP-7(rs11568818)

 AA

52 (34.7)

53 (35.3)

1

 AG

71 (47.3)

77 (51.3)

0.96 (0.56–1.65)

0.90

 GG

27 (18)

20 (13.3)

1.41 (0.66–2.99)

0.38

MMP-13(rs2252070)

 AA

79 (52.7)

70 (46.7)

1

 AG

60 (40)

70 (46.7)

0.78 (0.50–1.24)

0.30

 GG

11 (7.3)

10 (6.7)

0.95 (0.34–2.64)

0.92

MT2A(rs28366003)

 AA

131 (87.3)

139 (92.7)

1

 AG + GGb

19 (12.7)

11 (7.3)

1.76 (0.81–3.83)

0.15

  1. aMultivariable logistic regression adjusted for Zn level
  2. bGenotypes were summarized because of low number of GG genotype